[1]
“Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study”, Reumatismo, vol. 70, no. 2, pp. 67–71, Jul. 2018, doi: 10.4081/reumatismo.2018.1028.